The present invention relates to new triazolyl purine derivatives of formula I, processes for their preparation, and to pharmaceutical compositions containing them for the treatment of neurological disorders or cerebral ischaemia for which inhibition of adenosine A2Areceptor will result at improving the health state of a patient.本發明關於式I之新穎三唑基嘌呤衍生物,彼之製備方法及含有彼之醫藥組成物,其係用於治療神經性病症或大腦缺血症,以其抑制腺苷A2A受體導致改進病患的健康狀態。